The State of Texas has sued pharmaceutical firm Eli Lilly & Firm Inc., alleging the corporate engaged in improper practices to affect medical suppliers to prescribe its most commercially profitable medication, together with the GLP-1 medicines Mounjaro and Zepbound, that are indicated for weight reduction and diabetes administration.
Trending
- Best Early Labor Day Mattress Sales (2025)
- India should position weddings, MICE as niche tourism segment: Govt official | Travel
- Jason Bourne is coming back – but what do we want from him this time? | Jason Bourne
- The US economy is a puzzle but the pieces aren’t fitting together
- Why This 35mm Lens Might Be Nikon’s Best Prime Yet
- Cyber Insurers Owe Nearly $5M in Covered Losses, Lawsuit Alleges
- Kyte, which billed itself as the ‘best competitor to Hertz,’ shuts down
- A Comprehensive Glossary for Playwrights